Track the 에스케이바이오팜 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에스케이바이오팜 has logged 33 reports. Market capitalisation: €5,904.8bn. The latest transaction was disclosed on 1 April 2026 (Sale). Among the most active insiders: 조형래. Every trade is free.
33
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
2 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,569 of 29,063 companies
67.3
score / 100
Value
41
Quality
93
FCF yld2.5%
Earn yld4.5%
EV/EBITDA33.9x
ROE44%
Gross mgn94%
Net mgn38%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
SK Biopharmaceuticals es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de tratamientos innovadores para trastornos neurológicos y psiquiátricos.
